ABUS icon

Arbutus Biopharma

55 hedge funds and large institutions have $88.8M invested in Arbutus Biopharma in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

23% less capital invested

Capital invested by funds: $115M → $88.8M (-$26.2M)

48% less call options, than puts

Call options by funds: $620K | Put options by funds: $1.19M

Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$620K
Puts
$1.19M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$39.2M
2
$13M
3
$9.64M
4
$4.75M
5
$4.25M
6
$4.05M
7
$2.35M
8
$1.98M
9
$1.94M
10
$1.09M
11
$892K
12
$681K
13
$573K
14
$442K
15
$431K
16
$392K
17
$368K
18
$343K
19
$257K
20
$219K
21
$183K
22
$172K
23
$160K
24
$138K
25
$133K